 |
Tulane University School of Medicine | |
| City: New Orleans | State: LA | |
|
Links:
Commentary:Overall Tulane submits a weak policy. While the policy does discuss many of the domains, it does not effectively place meaningful restrictions on the business interactions between industry and faculty in such a manner to prevent potential conflicts of interest.
Updates: This institution did not provide any new or additional for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 03/16/2011 |
||
| Gifts & Meals |  |
Policy does not ban on-site meals, other limits placed on gifts or on-site meals are not significant. |
| Consulting relationships | |
While consulting relationships must be disclosed at least annually, without prior approval, there is no policy that requires payment commensurate with the task or that the relationship be described in a formal contract. |
| Industry-funded speaking relationships | |
All speaking arrangements must be disclosed, but the policy lacks a prohibition on participation in speakers bureaus, or limitations on the length of speaking engagments. |
| Disclosure | |
While the policy does require annual disclosure of all outside consulting relationships it only requires disclosure of financial interests greater than $10,000 or 5% of the company, this level is too high. A higher score would be possible if a lower financial interest level was used or if all clinicians were required to disclose to their patients as appropriate. |
| Pharmaceutical samples | |
No policy provided. |
| Purchasing & Formularies | |
While the policy does use the P&T committee as an example of a potential conflict of interest, there is no formalized policy surrounding P&T committees and the annual disclosure baseline of $10,000 is too high to be effective. |
| Industry Sales Representatives |  |
Industry sales representatives may not be in patient care areas. |
| On-campus Education | |
No policy provided. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Very limited policy with unclear restrictions or goals. |
| Industry Support for Scholarships & Funds for Trainees | |
The policy places no restrictions or oversight on industry scholarships. |
| Medical school curriculum |  |
No curriculum provided. |
| Do the policies specify an oversight mechanism? |  |
Oversight is designated. |
| Are there explicit sanctions for noncompliance? | |
Sanctions for non-compliance are referenced. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
